Clinical Trials

 

Studies of promising new or experimental therapies in patients are known as clinical trials. During a course of treatment for lung cancer, the doctor may suggest that a patient take part in a clinical trial of a new treatment. A clinical trial is only done when there is some reason to believe that the treatment being studied may be of value to the patient. Treatments used in clinical trials are often found to have real benefits.

ClinicalTrials.Gov - A Service of the U.S. National Institutes of Health

ClinicalTrials.gov, a primary resource for The Mesothelioma Cancer Alliance, is a registry of federally and privately sponsored clinical trials that are currently being conducted in the United States and 173 other countries around the world. The site was developed by the U.S. National Institutes of Health in collaboration with all NIH Institutes and the FDA following the Food and Drug Administration Modernization Act of 1997. ClinicalTrials.gov provides clinical trial information for a wide range of diseases including mesothelioma. The types of data reported on the site includes each trial’s objective, whether or not participants are being recruited, progress updates, locations, contact information and more